BioWin
Overview
BioWin is the health cluster of Wallonia, Belgium, dedicated to fostering innovation and collaboration in the biopharma and health-tech sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| PDC*line Pharma | Jan 2024 | Grant | Co-investor |
| Aquilon Pharmaceuticals | Aug 2023 | Grant | Co-investor |
| OncoDNA | Jan 2024 | Grant | Co-investor |
| Axinesis | - | Grant | Co-investor |
| Inteliphage | - | Grant | Co-investor |
For institutional investors. Book with your work email.
Key People
Sylvie Ponchaut
Managing Director, Scientific Director
David Honba
Chief Operating Officer
Thierry Ferain
Innovation & Scientific Excellence Program Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BioWin based?
BioWin is headquartered in Namur, Belgium.
When was BioWin founded?
BioWin was founded in 2006.
How many portfolio companies does BioWin have?
BioWin has 8 portfolio companies in Caplight's dataset.
What are some companies in BioWin's portfolio?
Portfolio companies visible on Caplight include PDC*line Pharma, Aquilon Pharmaceuticals, OncoDNA, Axinesis, Inteliphage.
What was BioWin's most recent investment shown here?
BioWin's most recent investment in this portfolio sample was in PDC*line Pharma in 2024.
What sectors does BioWin focus on?
BioWin focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software.
What company stages does BioWin focus on?
BioWin typically invests at the MultiStage stage.